The Co(II/III)-containing macrocycle,
cobalt 2,12-dimethyl-3,7,11,17-tetraazabicyclo-[11.3.1]-heptadeca-1(17)2,11,13,15-pentaenyl
cation, or CoN4[11.3.1], is a potential cyanide-scavenging
agent. The rate of reduction of Co(III)N4[11.3.1] by ascorbate
is reasonably facile under pseudo-first-order conditions; a second-order
rate constant of 11.7(±0.4) M–1 s–1 was determined at 25 °C and pH 7.4, along with the activation
parameters for the reaction (ΔH
⧧ = 53.9(±0.8) kJ mol–1; ΔS −79(±3) J mol–1 K–1). It follows that any cyanide-decorporating capability of the cobalt
complex should depend more on the cyanide-binding characteristics
of Co(II)N4[11.3.1] than the oxidized form. The kinetics
of the reaction of cyanide with Co(II)N4[11.3.1] under
anaerobic pseudo-first-order conditions is rapid and resulted in a
linear dependence on the cyanide concentration, k
HCN = 8 × 104 M–1 s–1, with a nonlinear intercept of 420 s–1 at 10 °C, pH 7.6. The observed reaction rate increases significantly
with increasing pH. A rate law is suggested, k
obs = k′[X] + (k
HCN + k
CN
K
a/[H+])[HCN], where k
CN is estimated to be ∼2 × 106 M–1 s–1. Activation parameters for the reaction with
HCN (ΔH
⧧ = 10.7(±0.4)
kJ mol–1; ΔS
⧧ = −153(±1) J mol–1 K–1) suggest an associative mechanism. In the presence of excess oxygen,
i.e., at higher levels than free oxygen in vivo,
the reaction rate was too fast to be measured, and the final product
was the oxidized complex, Co(III)N4[11.3.1], where any
cyanide ligands had been lost. This is much more rapid than the oxidation
of the parent compound by oxygen, for which a second-order rate constant
of 0.5(±0.02) M–1 s–1 at
25 °C was obtained. The study has gone some way toward enhancing
our understanding of the reaction of Co(II)N4[11.3.1] with
cyanide. The fast reaction rate implies a high efficacy of the cyanide-scavenging
capability of the complex and further supports the suggestion stemming
from our previous work that Co(II)N4[11.3.1] could prove
to be a better and more cost-effective cyanide antidote than the FDA-approved
hydroxocobalamin.